Depiction of France

France

Welcome to France

Our Paris office provides local and international clients with all that Oxera has to offer. Businesses, law firms, and regulators alike benefit from our many years of experience in the French market.

Led by experts in corporate finance, commercial disputes, and regulation, our Paris-based team can advise you on economic and finance issues relating to regulation, commercial litigation and arbitration, competition disputes, antitrust damages, and state aid. We work across a broad range of sectors including energy, transport, and financial services.

We’re proud that our work has changed the way that regulators and courts use economic thinking. Through our links with top Parisian business schools and universities, we offer you the best in academic innovation partnered with experience in both local and international markets.

Drawing on expertise from across Oxera’s network of European offices, academic Associates and Senior Advisers, our French- and English-speaking Paris team deliver the economics and finance insight that helps our clients make better decisions.

Local Insights

Depiction of COVID-19 and damages quantification: key challenges for the post-pandemic world
7 minute read

COVID-19 and damages quantification: key challenges for the post-pandemic world

The COVID-19 pandemic has caused large-scale disruptions to the global economy. One consequence is the emergence of commercial disputes following terminations or breaches of contracts during the pandemic. What challenges are likely to arise when quantifying damages in light of COVID-19 in commercial litigation or arbitration proceedings? Read More

Depiction of Practical guidance on the new state aid rules on public recapitalisations
11 minute read

Practical guidance on the new state aid rules on public recapitalisations

Under specific conditions, member states can provide aid in the form of subordinated debt, hybrid capital and equity in line with state aid rules to companies facing difficulties due to the COVID-19 pandemic. Read More

Depiction of COVID-19: a ‘material adverse change’ for merger remedies?
8 minute read

COVID-19: a ‘material adverse change’ for merger remedies?

Instead of blocking a merger, competition authorities across Europe and beyond may ask for commitments to address competition concerns with the concentration. In these cases, writes Oxera Partner Maurice de Valois Turk, the merger approval is conditional on the (implementation of) the commitments, and thus one could argue that the commitments (together with the approval) form a contract between the authority and the notifying firms. Read More

Depiction of What problems can the European Commission’s New Competition Tool fix?
10 minute read

What problems can the European Commission’s New Competition Tool fix?

On 2 June, the European Commission launched consultations on proposals for a New Competition Tool (NCT) and its Digital Services Act package. We look at the proposals for the NCT, drawing on lessons from the UK market investigations regime, and in particular the ability to use market investigations to act more quickly and effectively to remedy competition problems Read More

Oxera France

[email protected]

Oxera Consulting LLP (Paris)
21 Boulevard Haussmann
75009 Paris
+33 1 5603 6556